Coatue Management
GH icon

Coatue Management’s Guardant Health GH Stock Holding History

Coatue Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-261,603
Closed -$26.2M – 71
2021
Q4 		$26.2M Sell
261,603
-2,543,670
-91% -$263M 0.12% 55
2021
Q3 		$351M Buy
2,805,273
+144,070
+5% +$17.1M 1.43% 27
2021
Q2 		$330M Buy
2,661,203
+642,750
+32% +$86.5M 1.28% 27
2021
Q1 		$308M Buy
2,018,453
+899,916
+80% +$136M 1.69% 20
2020
Q4 		$144M Hold
1,118,537
– – 0.54% 38
2020
Q3 		$125M Sell
1,118,537
-456,440
-29% -$41.8M 0.66% 32
2020
Q2 		$128M Sell
1,574,977
-717,250
-31% -$57.8M 1.12% 26
2020
Q1 		$160M Buy
2,292,227
+340,347
+17% +$26.1M 2.02% 21
2019
Q4 		$153M Buy
1,951,880
+1,158,897
+146% +$83.5M 1.21% 27
2019
Q3 		$50.6M Sell
792,983
-403,013
-34% -$35.5M 0.43% 36
2019
Q2 		$103M Buy
+1,195,996
New +$91.3M 0.87% 28

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Coatue Management's GH Position: Q1 2022 in Review

Coatue Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 261,603 shares — an estimated $26.2M sold.

Coatue Management first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $351M in Q3 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Coatue Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Coatue Management sold 261,603 Guardant Health shares in Q1 2022, an estimated $26.2M.
  • Coatue Management first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
  • Coatue Management's Guardant Health position peaked at $351M in Q3 2021.
  • 355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Coatue Management's 13F filing for Q1 2022, filed 16 May 2022.